Page last updated: 2024-11-02

benoxinate and Facial Pain

benoxinate has been researched along with Facial Pain in 1 studies

benoxinate: RN given refers to parent cpd; structure
oxybuprocaine : A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blackwell, N1
Bax, K1
Adsett, S1

Other Studies

1 other study available for benoxinate and Facial Pain

ArticleYear
Topical ophthalmic anaesthesia for severe facial pain due to recurrent head and neck carcinoma.
    Palliative medicine, 1995, Volume: 9, Issue:3

    Topics: Anesthetics, Local; Cornea; Facial Pain; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplas

1995